Fineotex Chemical Limited

NSE:FCL.NS

286.5 (INR) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 1,457.2731,419.0061,530.1721,384.5181,452.6811,322.3321,376.8951,092.2961,343.1081,357.6571,198.861,050.728784.908632.757750.209583.528547.455303.871435.832520.546510.442496.537488.806460.065432.044428.535242.616356.801348.596303.491392.579298.502293.613295.982285.297294.417314.222252.989282.516241.998289.101255.375661.992106.81699.22490.477
Cost of Revenue 900.238949.9921,026.053879.175891.008834.63878.141642.164925.6871,005.172808.351649.53494.009413.106487.424349.615358.993209.707265.499330.652316.099319.169334.379299.22288.149260.972150.54219.336203.762170.684238.784171.557171.731177.038159.604186.656198.051149.04182.616156.139219.618176.782478.61782.82666.92464.847
Gross Profit 557.035469.014504.119505.343561.673487.702498.754450.132417.421352.485390.509401.198290.899219.651262.785233.913188.46294.164170.333189.894194.343177.368154.427160.845143.895167.56392.076137.465144.834132.807153.795126.945121.882118.944125.693107.761116.171103.94999.985.85969.48378.593183.37623.9932.325.63
Gross Profit Ratio 0.3820.3310.3290.3650.3870.3690.3620.4120.3110.260.3260.3820.3710.3470.350.4010.3440.310.3910.3650.3810.3570.3160.350.3330.3910.380.3850.4150.4380.3920.4250.4150.4020.4410.3660.370.4110.3540.3550.240.3080.2770.2250.3260.283
Reseach & Development Expenses 0000006.0470004.44200000000000000000000000000000000000
General & Administrative Expenses 000000118.88900063.682000104.73200041.25300031.00300028.33900024.32700018.7580000000006.3768.864
Selling & Marketing Expenses 0000002.7690003.8290002.4620002.1570002.8310009.710006.6440001.03300000000000
SG&A 0138.963139.723116.126129.08251.229121.658118.551121.88143.11367.51135.98931.01195.097107.19426.18419.65615.60443.4120.91221.04619.85333.83418.85418.60417.36238.04917.0841512.53530.97111.16110.69911.17919.79110.2928.0938.94316.9488.7226.5048.05006.3768.864
Other Expenses 557.035041.46149.35238.1236.44220.8717.94824.7359.491-48.56511.84612.91728.05921.1899.8634.15853.0614.11331.314-7.099-0.592.7935.551-2.546-4.9657.0726.5719.46756.62653.47245.77939.36947.86140.84237.88640.87841.50168.38233.57929.60541.825179.084-3.144-2.160.095
Operating Expenses 557.035138.963139.723116.126193.621185.758183.284175.625176.7158.946178.934156.661148.056126.428138.344101.67792.27756.497.987112.71996.0394.90672.66779.34667.58569.65234.17826.5766.16756.62653.47245.77939.36947.86140.84237.88640.87841.50168.38233.57929.60541.825179.084-3.1444.2168.959
Operating Income 340.201330.051364.396389.217406.172301.944336.341292.455265.455252.449213.264244.537142.84393.223124.441132.23696.18537.76472.34677.17598.31382.46281.7681.49976.3197.91157.898109.29378.66775.05999.35879.99181.67470.15583.85769.05174.50461.16976.04751.47239.03935.894.29127.13428.08416.671
Operating Income Ratio 0.2330.2330.2380.2810.280.2280.2440.2680.1980.1860.1780.2330.1820.1470.1660.2270.1760.1240.1660.1480.1930.1660.1670.1770.1770.2280.2390.3060.2260.2470.2530.2680.2780.2370.2940.2350.2370.2420.2690.2130.1350.1410.0060.2540.2830.184
Total Other Income Expenses Net 66.84846.288-44.96946.40535.4834.56413.80415.93222.4548.157-5.0139.02410.83225.85826.668-22.59936.64151.807-129.62929.728-8.745-2.0411.6653.637-5.535-10.9396.086-11.088-32.9510.0018.410.24105.601-0.00100-0.001173.648-0.0010048.442-11.121-1.031-1.133
Income Before Tax 407.049376.339400.007435.622403.532336.508333.765290.439263.175260.606206.562253.561153.675119.081151.109185.131132.82689.571-57.283106.90389.56880.42293.42585.13670.77586.97263.984109.29396.88375.0699.35879.99281.67470.15683.85669.05174.50461.16976.04751.47239.03935.8952.73416.01327.05315.538
Income Before Tax Ratio 0.2790.2650.2610.3150.2780.2540.2420.2660.1960.1920.1720.2410.1960.1880.2010.3170.2430.295-0.1310.2050.1750.1620.1910.1850.1640.2030.2640.3060.2780.2470.2530.2680.2780.2370.2940.2350.2370.2420.2690.2130.1350.1410.080.150.2730.172
Income Tax Expense 86.36784.56695.254106.37188.58275.21673.76965.68455.44257.54536.60162.74342.46522.17431.57351.16122.7537.5894.04425.95223.62222.89628.29721.93820.52322.22528.23218.62431.21919.124.77126.01821.2820.46826.83822.36222.82419.41923.54813.5718.35310.56614.5863.0747.5165.044
Net Income 318.535287.512301.068326.713313.549256.758258.158221.535205.743197.722165.246184.603107.19394.702112.216130.797104.88777.975-63.05476.53862.02755.21961.5656.98245.0361.55935.75288.12162.24652.60764.92742.3460.6543.81449.6440.30843.96836.48745.51733.07429.39621.79227.39412.93919.53710.494
Net Income Ratio 0.2190.2030.1970.2360.2160.1940.1870.2030.1530.1460.1380.1760.1370.150.150.2240.1920.257-0.1450.1470.1220.1110.1260.1240.1040.1440.1470.2470.1790.1730.1650.1420.2070.1480.1740.1370.140.1440.1610.1370.1020.0850.0410.1210.1970.116
EPS 2.82.562.722.952.832.322.3321.861.791.491.670.970.861.011.180.950.7-0.570.690.560.50.560.510.40.550.320.790.560.470.580.380.540.390.440.360.390.320.410.290.260.190.250.120.170.093
EPS Diluted 2.82.562.722.952.832.322.3321.861.791.491.670.970.861.011.180.950.7-0.570.690.560.50.560.510.40.550.320.790.560.470.580.380.540.390.440.360.390.320.410.290.260.190.250.120.170.093
EBITDA 432.92401.288424.36452.875420.226351.726347.962303.451275.67271.907217.517262.624160.853126.247157.62190.83137.68494.174-52.364111.49593.93384.53897.34889.62976.33491.34766.691112.47699.68277.739102.1482.87184.14866.03586.48971.18676.56663.81874.98454.3641.11538.071-7.80727.64628.59417.173
EBITDA Ratio 0.2970.2830.250.2910.2890.2660.2530.2780.2050.20.1760.250.2050.20.20.250.310.310.1830.2140.1840.170.1780.1950.1770.2220.2750.3150.2860.2560.260.2780.2870.2450.3030.2420.2440.2520.2650.2250.1420.149-0.0120.2590.2880.19